| [1] | 葛均波,徐永健.内科学[M].8版.北京:人民卫生出版社,2013:689. |
| [2] | 中华医学会.临床诊疗指南核医学分册[M].北京:人民卫生出版社,2006:94-95. |
| [3] | 邹大进,李娟.甲状腺功能亢进症伴粒细胞减少的诊断与处理[J].中国实用内科杂志,2006,26(9):645-646. |
| [4] | |
| [5] | 吴嘉俐.甲状腺功能亢进症合并白细胞减少60 例临床观察[J].华中医学杂志,2008,32(5):367. |
| [6] | Vyas AA,Vyas P,Fillipon NL,et al.Successful treatmentof thyroid storm with plasmapheresis in a patient with methimazole-induced agranulocytosis[J].Endocr Pract,2010,16(4):673. |
| [7] | Klecha AJ,Barreiro Arcos ML,Frick L,et al.Immune-endocrine interactions in autoimmune thryiod diseases[J].Neuroimmunomodulation,2008,15(1):68-75. |
| [8] | 徐艳,高艳玲,孙枫.Graves病合并白细胞减少的临床分析[J].中国全科学,2011,14(6):2075-2077. |
| [9] | 郭满涛,李亚明,尹雅芙,等.甲状腺功能亢进伴白细胞减少患者放射性碘治疗早期白细胞变化随访研究[J].重庆医学,2012,41(1):28-29. |
| [10] | 周斌,文格波.抗甲状腺药物致Graves病患者粒细胞减少或缺乏研究进展[J].临床药学,2007,13(7):544-545. |
| [11] | Ahmed K,Rao S,Simha V.Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with graves disease:cross-reaction between propylthiouracil and methimazole[J].Endocr Pract,2010,16(3):449-451. |
| [12] | Sun MT,Tsai CH,Shih KC.Antithyroid drug-induced agranulocytosis[J].Chin Med Assoc,2009,72( 8):438-441. |
| [13] | Brent GA.Clinical practice.Graves'disease [J].N Ensl J Med,2008,358(24):2594-2605. |
| [14] | 谭健.治疗131I治疗Graves甲状腺功能亢进症专家共识解读[J].国际内分泌代谢杂志,2012,32(2):73-75. |
| [15] | 黄勤,邹大进,潘文舟.131I治疗伴白细胞减少Graves病的临床观察[J].中华内分泌代谢杂志,2006,16(3):184-185. |
| [16] | 王荣福,李少林.核医学教师用书[M].北京:人民卫生出版社,2008:538-539. |